[CLSTR]
< Back to situations

[ORGANIZATION]

Hanmi Pharmaceutical

Featured in 8 tracked stories · first seen

Situations

[ACTIVE] [TECHNOLOGY] [KR] [US]

South Korea advances sovereign AI and specialized AI agents

18 clusters · 31 sources · last updated

Latest: South Korea to release AI-friendly 2027 budget proposals

In late August 2026, South Korea intensified its focus on sovereign AI and the deployment of specialized AI agents across public, financial, and educational sectors. Under the ‘AI for All Project,’ the government is adva

[ACTIVE] [TECHNOLOGY] [KR] [AE] [EG]

South Korean medical tech and AI sovereignty expansion

5 clusters · 9 sources · last updated

Latest: South Korean health agencies host medical regulation and AI innovation events

South Korean medical technology and biotechnology companies are expanding their global footprint through specialized innovations and high-value technology exports. In the medical AI and device sectors, firms like Vuno, G

[QUIET] [BUSINESS] [KR]

South Korean corporate AI integration

2 clusters · 7 sources · last updated

Latest: Hanmi Pharmaceutical to automate quality assurance using AI

South Korean companies are increasingly adopting artificial intelligence to automate specialized business operations and workflows. Hancom entered a memorandum of understanding with Namyang Dairy Products to conduct a P

[QUIET] [BUSINESS] [KR] [CH] [US]

Hanmi Pharmaceutical obesity drug development

2 clusters · 13 sources · last updated

Latest: Hanmi Pharmaceutical to produce documentary on obesity drug Epe

Hanmi Pharmaceutical is advancing its obesity and metabolic disease drug pipeline through both international licensing and domestic development. In late August 2026, Hanmi entered an exclusive licensing agreement with G

Also covered in